Healthcare and Pharmaceuticals
Global Smart Pills Technology Market was valued at USD 2.62 Billion in the year 2017. Global Smart Pills Technology Market is further estimated to grow at a CAGR of 21% from 2018 to reach USD 8.22 Billion by the year 2023. The smart pill is a wireless capsule that can be swallowed, and with the help of a receiver (worn by patients) and software that analyzes the pictures captured by the smart pill, the physician is effectively able to examine the gastrointestinal tract.
The global Smart Pills Technology Market is segmented on the basis of technology, disease indication and by region. On the basis of technology, the market is segmented Capsule Endoscopy, Patient Monitoring and Drug Delivery of which Capsule Endoscopy segment is expected to hold the highest market share during the forecast period and are expected to grow with highest CAGR. On the basis of Disease Indications, the market is segmented as Occult GI Bleeding, Crohn’s Disease, Small Bowel Tumors, Celiac Disease, Inherited Polyposis Syndromes and Others in which Occult GI Bleeding segment holds the highest market share in the forecasted period.
North America region holds the highest market share in 2017 and the Asia Pacific is considered as the fastest growing market in the forecasted period. At a country level, the U.S is the major markets in North America region and holds a substantial market share in 2017 and it is projected to grow at a gradual pace in the coming years. North America is anticipated to dominate the market during the analysis period, due to the presence of high-quality healthcare systems and modern medical technology in the country.
Drivers:
Increasing Preference for Minimally Invasive Device.
Technological Advancements in Capsule Endoscopes.
Rise in Incidences of Colon Cancer.
Restraints:
Technological Incompetence of Capsule Endoscopes.
Ethical Constraints.
Opportunities:
Need for Rapid Drug Development Process.
Challenges:
Potential Health Risks.
Increasing Cost with Technological Advancement.
Given Imaging Inc. (Israel), Olympus Corporation (Japan), CapsoVision Inc. (U.S), Bio-Images Research Ltd. (U.K), Boston Scientific Corporation (U.S), Ge Healthcare (U.S) and Novartis AG (Switzerland) are some of the key players in the global Smart Pills Technology Market. Rising research and development expenses to address the changing demand of end users. Similarly, growth strategies such as acquisition, merger, and expansion of the distribution network were few techniques adopted by most of the top players in the last 5 years.
Key Benefits for Stakeholders
Smart Pills Technology product manufacturers
Healthcare professionals and R&D centers
Research and Consulting organization
Government agencies & authorities
By Technology
Capsule Endoscopy
Small Bowel Video Capsule Endoscopy
Colon Capsule Endoscopy
Patient Monitoring
Drug Delivery
By Disease Indications
Occult GI Bleeding
Crohn’s Disease
Small Bowel Tumors
Celiac Disease
Inherited Polyposis Syndromes
Others
By Region
North America
Europe
Asia-Pacific
RoW
Key Market Players
Given Imaging Inc.
Olympus Corporation
Capso Vision Inc.
Bio-Images Research Ltd.
Boston Scientific Corporation
Ge Healthcare
Acamp
Novartis AG
Microchips
Vitality
(Another brief information of 10 companies will be provided in the report)
Research Methodology:
Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –
Detailed customization is also available for you. Further, if the report listed above does not meet wour key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.
1. Introduction
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Limitations
1.3 Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.1.1. Key Data from Secondary Research
2.1.2. Primary Research
2.1.2.1. Key Data from Primary Research
2.1.2.2. Breakdowns of Primary Interviews
2.2. Market Size Estimation
2.2.1. Bottoms-Up Approach
2.2.2. Top-Down Approach
2.2.3. Annual Revenue Process
2.3. Data Triangulation
2.4. Research Assumptions
2.4.1. Assumption
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Challenges
4.6. Regulations
4.7. Supply Chain/Value Chain Analysis
4.8. Patent & Standards
5. Industry Trends
5.1. Introduction
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Buyers
5.2.4. Bargaining Power of Suppliers
5.2.5. Intensity of Competitive Rivalry
6. Global Smart Pills Technology Market, By Technology
6.1 Capsule Endoscopy
6.1.1 Small Bowel Video Capsule Endoscopy
6.1.2 Colon Capsule Endoscopy
6.2 Patient Monitoring
6.3 Drug Delivery
7. Global Smart Pills Technology Market, By Disease Indications
7.1 Occult GI Bleeding
7.2 Crohn’s Disease
7.3 Small Bowel Tumors
7.4 Celiac Disease
7.5 Inherited Polyposis Syndromes
7.6 Others
8. Geographical Analysis
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. U.K.
8.3.2. Germany
8.3.3. Italy
8.3.4. France
8.3.5. RoE
8.4. Asia Pacific
8.4.1. South Korea
8.4.2. China
8.4.3. Japan
8.4.4. South Korea
8.4.5. RoAPAC
8.5. RoW
8.5.1. Latin America
8.5.2. Middle East and Africa
9. Company Profiles
(Business Overview, Financial Overview, Product write Up, Recent Developments)
9.1 Given Imaging Inc.
9.2 Olympus Corporation
9.3 CapsoVision Inc.
9.4 Bio-Images Research Ltd.
9.5 Boston Scientific Corporation
9.6 Ge Healthcare
9.7 Acamp
9.8 Novartis AG
9.9 Microchips
9.10 Vitality
(Another brief information of 10 companies will be provided in the report)
10. Competitive Analysis
10.1. Introduction
10.2. Market Positioning of Key Players
10.3 Competitive Strategies Adopted by Leading Players
10.3.1. Investments & Expansions
10.3.2. New Product Launches
10.3.3. Mergers & Acquisitions
10.3.4. Agreements, Joint Ventures, and Partnerships
11. Appendix
11.1. Questionnaire
11.2. Available Customizations
11.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)
No Content Available.